Health systems across the nation are reporting shortages in sotrovimab, which The New York Times reported is the only COVID-19 monoclonal antibody treatment that appears to be effective against the omicron variant.
Category: Supply Chain
10 systems seeking supply chain talent
Ten health systems have posted job listings for supply chain expertise in the last week:
Antigen tests may be less sensitive to omicron, FDA warns
Rapid antigen tests may have reduced sensitivity in detecting the omicron COVID-19 variant, the FDA said in a Dec. 28 update.
377K portable bed rails recalled after 4 deaths
The U.S. Consumer Product Safety Commission recalled around 377,000 portable bed rails from Middleburg Heights, Ohio-based Compass Health and Orlando, Fla.-based Essential Medical Supply in two separate Dec. 22 announcements.
Amazon limiting sales for at-home COVID-19 test kits as demand surges
Amazon is limiting sales of its at-home COVID-19 PCR test kit to 10 units per shopper due to supply shortages, CNBC reported Dec. 22.
COVID-19 test shortages will ease in January, Fauci says
As the U.S. struggles to keep up with COVID-19 testing demands, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, said he expects test supply levels to improve in January, according to ABC News.
10 systems seeking supply chain talent
Ten health systems have posted job listings for supply chain expertise in the last week:
Most monoclonal antibody treatments fail against omicron, other in short supply
Two of the three monoclonal antibody treatments used to prevent COVID-19 patients from becoming severely sick don’t appear to be effective against the omicron coronavirus variant, The New York Times reported Dec. 21.
US medical supplies delayed an average of 37 days industrywide
U.S. medical providers are seeing long delays in the delivery of medical supplies, according to a Dec. 17 Health Industry Distributors Association report.
Procter & Gamble recalls 30 aerosol spray products over cancer-causing chemical
Procter & Gamble on Dec. 17 recalled more than 30 aerosol spray hair care products, including many dry shampoos and dry conditioners, because of the detection of benzene, a cancer-causing agent, in some products.
